BioDlink Completes First International Shipment of Bevacizumab to Colombia
- Written by PR Newswire
 |
- Bevacizumab is a targeted therapy used to treat lung and colorectal cancers, both among the top three cancers ranked by death in Colombia[1].
- This inaugural shipment—dispatched around two months after Colombia's marketing approval—demonstrates the company's efficiency, while validating its antibody commercialization platform, as well as...
